Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 11.769% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
[a] O=C(Cc1ccccc1)NCC(=O)OCC(=O)c1cccs1
[b] CC(Oc1ccc2c(-c3ccccc3)cc(=O)oc2c1)C(=O)NCC1CCC(C(=O)O)CC1
[c] CC[C@H](C)[C@@H]1NC(=O)c2cc([N+](=O)[O-])cc(I)c2SC[C@@H](C(N)=O)NC(=O)[C@H](CCCCN)NC1=O
[d] Cc1cc2ccccn2c1C(=O)c1nc(NCc2ccccc2)ncc1Cl
Answer: d. Cc1cc2ccccn2c1C(=O)c1nc(NCc2ccccc2)ncc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc2ccccn2c1C(=O)c1nc(NCc2ccccc2)ncc1Cl
Cc1cc2ccccn2c1C(=O)c1nc(NCc2ccccc2)ncc1Cl
[2-(benzylamino)-5-chloropyrimidin-4-yl]-(2-methylindolizin-3-yl)methanone